| MolName | (5Z)-3-cyclohexyl-5-[(4-oxo-2-pyrrolidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C22H24N4O2S2 |
| Smiles | O=C(/C(/S1)=C/C2=C(N3CCCC3)N=C(C=CC=C3)N3C2=O)N(C2CCCCC2)C1=S |
| InChI | InChI=1S/C22H24N4O2S2/c27-20-16(14-17-21(28)26(22(29)30-17)15-8-2-1-3-9-15)19(24-11-6-7-12-24)23-18-10-4-5-13-25(18)20/h4-5,10,13-15H,1-3,6-9,11-12H2 |
| InChIK | LEZRNFLLGOKNKL-UHFFFAOYSA-N |
| TotalMolweight | 440.591 |
| Molweight | 440.591 |
| MonoisotopicMass | 440.134066 |
| CLogP | 1.878 |
| CLogS | -5.35 |
| H Acceptors | 6 |
| TotalSurfaceArea | 322.54 |
| Relative PSA | 0.2906 |
| PolarSurfaceArea | 113.61 |
| Druglikeness | 1.1438 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.46667 |
| Fragments | 1 |
| Non HAtoms | 30 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| Rotatable Bond | 3 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Sp3Atoms | 12 |
| Symmetricatoms | 4 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - (5Z)-3-cyclohexyl-5-[(4-oxo-2-pyrrolidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-cyclohexyl-5-[(4-oxo-2-pyrrolidin-1-ylpyrido[1,2-a]pyrimidin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one